Get started
Author

Cédric Mercier

Common Strategy for Adult and Pediatric Medulloblastoma: A Multicenter Series of 253 Adults
2007 · Laetitia Padovani, Marie-Pierre Sunyach, et al. · International Journal of Radiation Oncology*Biology*Physics · 153
Cytidine Deaminase Residual Activity in Serum Is a Predictive Marker of Early Severe Toxicities in Adults After Gemcitabine-Based Chemotherapies
2009 · Joseph Ciccolini, Laetitia Dahan, et al. · Journal of Clinical Oncology · 136
A Rapid and Inexpensive Method for Anticipating Severe Toxicity to Fluorouracil and Fluorouracil-based Chemotherapy
2006 · Joseph Ciccolini, Cédric Mercier, et al. · Therapeutic Drug Monitoring · 89
Routine Dihydropyrimidine Dehydrogenase Testing for Anticipating 5-Fluorouracil–Related Severe Toxicities: Hype or Hope?
2010 · Joseph Ciccolini, Eva Gross, et al. · Clinical Colorectal Cancer · 87
A simple and rapid high-performance liquid chromatographic (HPLC) method for 5-fluorouracil (5-FU) assay in plasma and possible detection of patients with impaired dihydropyrimidine dehydrogenase (DPD) activity
2004 · J. Ciccolini, C. Mercier, et al. · Journal of Clinical Pharmacy and Therapeutics · 83
PDF
DPD-based adaptive dosing of 5-FU in patients with head and neck cancer: impact on treatment efficacy and toxicity
2010 · Chen Guang Yang, Joseph Ciccolini, et al. · Cancer Chemotherapy and Pharmacology · 81
Integrating pharmacogenetics into gemcitabine dosing—time for a change?
2011 · Joseph Ciccolini, Cédric Mercier, et al. · Nature Reviews Clinical Oncology · 79
Profiling Dihydropyrimidine Dehydrogenase Deficiency in Patients with Cancer Undergoing 5-Fluorouracil/Capecitabine Therapy
2006 · Cédric Mercier, Joseph Ciccolini · Clinical Colorectal Cancer · 71
Toxic death case in a patient undergoing gemcitabine-based chemotherapy in relation with cytidine deaminase downregulation
2007 · Cédric Mercier, Caroline Raynal, et al. · Pharmacogenetics and Genomics · 58
High-dose methotrexate in adults with osteosarcoma: a population pharmacokinetics study and validation of a new limited sampling strategy
2008 · Charlotte Dupuis, Cedric Mercier, et al. · Anti-Cancer Drugs · 53
Early severe toxicities after capecitabine intake: possible implication of a cytidine deaminase extensive metabolizer profile
2008 · Cedric Mercier, Charlotte Dupuis, et al. · Cancer Chemotherapy and Pharmacology · 47
5-FU-induced neurotoxicity in cancer patients with profound DPD deficiency syndrome: a report of two cases
2011 · Pierre-Yves Cordier, André Nau, et al. · Cancer Chemotherapy and Pharmacology · 45
Toxic death-case after capecitabine + oxaliplatin (XELOX) administration: probable implication of dihydropyrimidine deshydrogenase deficiency
2005 · Joseph Ciccolini, Cedric Mercier, et al. · Cancer Chemotherapy and Pharmacology · 44
Severe or lethal toxicities upon capecitabine intake: is DPYD genetic polymorphism the ideal culprit?
2007 · Cédric Mercier, Joseph Ciccolini · Trends in Pharmacological Sciences · 34
Sudden Death Related to Toxicity in a Patient on Capecitabine and Irinotecan Plus Bevacizumab Intake: Pharmacogenetic Implications
2011 · Laetitia Dahan, Joseph Ciccolini, et al. · Journal of Clinical Oncology · 28
PDF
Pulmonary hypertension in patients with myeloproliferative neoplasms: A large cohort of 183 patients
2019 · Geoffroy Venton, Mihai Turcanu, et al. · European Journal of Internal Medicine · 26
In vitro and in vivo reversal of resistance to 5-fluorouracil in colorectal cancer cells with a novel stealth double-liposomal formulation
2007 · R Fanciullino, S Giacometti, et al. · British Journal of Cancer · 25
PDF
Dose Individualization of Carboplatin After a 120-hour Infusion Schedule: Higher Dose Intensity but Fewer Toxicities
2006 · Cédric Mercier, Joseph Ciccolini, et al. · Therapeutic Drug Monitoring · 24
High-Resolution Melting Analysis of Sequence Variations in the Cytidine Deaminase Gene (CDA) in Patients With Cancer Treated With Gemcitabine
2010 · Caroline Raynal, Joseph Ciccolini, et al. · Therapeutic Drug Monitoring · 23
CDA Deficiency as a Possible Culprit for Life-Threatening Toxicities After Cytarabine Plus 6-Mercaptopurine Therapy: Pharmacogenetic Investigations
2012 · Joseph Ciccolini, Alexandre Evrard, et al. · Pharmacogenomics · 21
Pulmonary hypertension in patients with chronic myeloproliferative neoplasms
2013 · Safia Chebrek, Karim Aïssi, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 20
Genotype-Based Methods for Anticipating Gemcitabine-Related Severe Toxicities May Lead to False-Negative Results
2007 · Cédric Mercier, Alexandre Evrard, et al. · Journal of Clinical Oncology · 20
Yin and Yang of Cytidine Deaminase Roles in Clinical Response to Azacitidine in the Elderly: A Pharmacogenetics Tale
2015 · Raphaelle Fanciullino, Cédric Mercier, et al. · Pharmacogenomics · 19
Lethal toxicity after administration of azacytidine
2015 · Raphaelle Fanciullino, Cedric Mercier, et al. · Pharmacogenetics and Genomics · 15
Genetic and biochemical modulation of 5-fluorouracil through the overexpression of thymidine kinase: an in-vitro study
2006 · Raphaelle Fanciullino, Alexandre Evrard, et al. · Anti-Cancer Drugs · 15
Works count: 67
Citation count: 1,414
H-index: 20
I10-index: 28
Year
Topic
Type